Iris Uniroma1 Prodmetadata only
A phase IV trial to confirm the efficacy of olaparib in combination with bevacizumab as maintenance frontline treatment of HRD-positive ovarian tumours (IOlanTHe)
auto, research
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 243852
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.